Introduction
Diabetes Mellitus (DM) is a disordered metabolic syndrome with hyperglycaemia either due to defect in insulin secretion or insulin resistance. It may cause progressive tissue damage and both micro and macrovascular complications. More than 95% of diabetes are type 2 DM. They always had insidious, latent, along with asymptomatic phase. Therefore management of DM has changed not only controlling symptoms but also preventing complications.
BMI (Body Mass Index) of any indian of more than 23 must be investigated for diabetes 1 . The waist circumference of more than 85cm in males and 80cm in females are the persons must be screened for DM. The yearly screening for glycated hemoglobin and TOD (Target organ damage) is a must. Coronary heart disease, atherosclerotic CHD, is the common impact of death worldwide in type 2 DM..INTERHEART -10 % of the population attributable risk of a first MI. High rate of asymptomatic coronary disease in type 2 DM. There will be a reduced myocardial flow reserve in type 2 DM. Hyperglycaemia decreases endothelium-derived NO availability and affects vascular function mainly through the increased production of ROS. Asymptomatic Diabetes mellitus higher median CAC scores raising frequency of silent ST segment depression and coronary perfusion changes during exercise testing. Stress treadmill test is a readily available, cost effective, first line test for identification of coronary heart disease in DM of longer duration without any symptoms of angina. This study was outlined to determine SMI (Silent Myocardial Ischemia) in selected asymptomatic DM outpatients by exercise tread mill test.
IV. Results
We studied around 50 outpatients of asymptomatic type 2 DM beyond clinical and electrocardiographic documentation of CAD in Coimbatore Medical college hospital, Coimbatore, and following results were noted. This table shows, more number of patients (26 i.e., 52%) were having diabetes equal to or less than 5 years, followed by 12 patients (24%) with the duration of 6-10 years, next 7 patients (14%) between 11-15 years and only 5 patients (10%) between 16-20 years. In the study population, more number of patients (26 i.e., 52%) were having diabetes equal to or less than 5 years, followed by 12 patients (24%) with the duration of 6-10 years, next 7 patients (14%) between 11-15 years and only 5 patients (10%) between 16-20 years. Out of 50 cases Treadmill test was positive in 15 (30%) and negative in 35(70%) patients. Tread mill test was positive in 4/26 (27%), 3/9 (20%), 5/7 (33%) and 3/5(20%) patient with duration of diabetes ≤5, 6 to 10, 1 to 15, and 16-20 years respectively.
This shows the relation of silent myocardial ischemia and duration of diabetes mellitus. In the present study out of 50 cases Treadmill test was positive in 15 (30%) and negative in 35(70%) patients. Tread mill test was positive in 4/26 (27%), 3/9 (20%), 5/7 (33%) and 3/5(20%) patient with duration of diabetes ≤5, 6 to 10, 1 to 15, and 16-20 years respectively. This shows longer the duration of diabetes, greater the risk of silent myocardial ischemia. The observation made with treadmill testing is as follows with reference to average duration of diabetes, HbA1C levels and triglycerides levels; It was found that there was a statistically significant difference in Tread mill test positive cases and Tread mill test negative cases with reference to the average age, duration of DM (p=0.001), average HbA1C levels (p=0.001) and triglycerides levels (p=0.001).
Average 
V. Discussion
Coronary Artery Disease detection in asymptomatic type 2 DM is often delayed. The preponderance of SMI in type 2 DM is variable and ranges from 9to75%.
3,4,5 My study was anticipated at the asymptomatic presentation of CAD in the form of (SMI) in asymptomatic DM patients. It consisted of two aspects; First the prevalence of SMI in asymptomatic patients with type2 DM. Secondly to assess clinical predictors of SMI in these patients.
This study consists of 50 asymptomatic type 2 diabetics without clinical and electrocardiographic evidence of CAD and were evaluated for the preponderance of SMI by using exercise treadmill testing.
Out of 50 cases 39 were males and 11 were females. In the age group of 31-40 yrs of age 5 patients are present. 3 were males, 2 were females .In the age group of 41-50 yrs of age 26 were present ,22 were males, 4 were females. In the 51-60yrs of age group 14 were males, 5 were females. Most patientsin the age group of 41-50 yrs of age.
25 (50%) patients were with normal body mass index, 16 patients (32%) were overweight while only 9 (18%) patients were obese. In the study population, more number of patients (26 i.e., 52%) were having diabetes equal to or less than 5 years, followed by 12 patients (24%) with the duration of 6-10 years, next 7 patients (14%) between 11-15 years and only 5 patients (10%) between 16-20 years.
As the duration of diabetes increased there is a increase in HbA1C level in cases of duration of diabetes >15 yrs duration of diabetes. This shows poor glycemic index. There is a statistically significant difference between duration of DM and HbA1C level.
In our50 patients, 2 (8%) was on diet control alone, 25 (50%) were on one or other OHA's, 11 (22%) were on one or other form of insulin while 12 (24%) were receiving both OHA's and insulin. There is a significant difference between duration of diabetes and treatment regimen.
Out of 50 cases TMT positive cases are 15 (30%) and negative cases are 35(70%) patients .The study shows the prevalence of SMI in type 2 asymptomatic DM was turned out to be 30% (15/50).
Our findings were similar to previous studies. One study 6 found that 29% diabetes who were asymptomatic for CAD had SMI on 24 hour ambulatory monitoring exercise electrocardiogram.Another similar study 7 had shown higher predominance of SMI in DM as compared to non diabetics. Another study 8 in India identified that 38.3% of DM beyond prior CAD had SMI on treadmill test.Another study 8 from India, reported 50% incidence of silent myocardial ischemia in diabetics on exercise electrocardiogram and 35% on ambulatory monitoring.Yet another group 9 found 12.1% of diabetics free of CAD to have SMI on exercise electrocardiogram testing.Another study 10 , found that SMI was positive in 14(46.7%) out of 30 DM patients by treadmill test.One more study population 11 identified that a total of 113/522 patients (22%) had SMI using stress testing in asymptomatic patients with type 2 diabetes mellitus.
One more study 12 found that 62/500 patients (12.4%) had SMI in outpatients with type DM by using exercise electrocardiogram. So in my study it shows that DM patients had a higher prevalence of silent myocardial ischemia.
Durationof Type 2 Diabetes Mellitus And Silent Myocardialischemia. In 50outpatients, Treadmill test positive cases are 15 patients (30%) and negative cases are 35 patients(70%).
 26 patients with diabetes duration equal to or less than 5 years, Tread mill test was positive in 3(11%). Our results are similar to one study 13 that found that 70% subjects (7/10) with DM of <5 years duration had associated silent myocardial ischemia while only 30% subjects (3/10) with DM of >5years duration had associated SMI.Another study 14 including 500 patients with type 2 diabetes mellitus with normal resting ECG found that, 62(12.4%) patients had asymptomatic coronary artery disease on exercise treadmill testing. The abnormalities of exercise test were associated with longer duration of diabetes(p<0.005).
Silent Myocardial Ischemia And Autonomic Neuropathy:
In our study, 60% of subject s (8/13) with autonomic neuropathy (AN) had silent myocardial ischemia while only 18.9% of subjects (7/37) without autonomic neuropathy had myocardial ischemia. Hence it depicts that,DM patients with AN hadm u c h higheroccurrence of SMI than those without it(60%Vs18.9%) of studies.
One group 15 depictsthat in a DM population of already known or doubtful CAD had SMI much more common with AN (92%Vs39%).
Another study in India 16 showed that 38.3% had SMI with a greater prevalence in those with AN( 59%) than those without it(20%).Another studyfrom India found that occurrence of SMI was higher in patients with AN 12/13(40%) compared to those without 3/30(10%) p<0.001.
Dyslipidemia And Silent Myocardial Ischemia:
In the present study, we found average total cholesterol in TMT positive and negative cases were 174.4mg% and 180.9mg % respectively. Average triglyceride in Treadmill test positive and negative cases 176.6mg% and 130.5mg% respectively. Statistically significant value of p<0.001 was found in triglycerides levels between both the groups.
The same results were observed in previous study 17 which found that dyslipidemia was common in type 2DM and the most common aberrancy was elevated serum triglyceride levels (73.3%).The next aberrancy was decreased serum HDL levels(66.7%).Another study from India 18 , found that CAD had strong complementation with elevated levels of triglycerides (0.82) and low HDL (-0.81).Yet another study 17 found that triglyceride levels were elevated in 28 treadmill positive cases compared to 15 treadmill negative cases (p<0.01).
Glycosylated Hemoglobin And Silent Myocardial Ischemia
The increased levels of glycosylated hemoglobin indicated poor glycemic control and it has great influence on CAD. In our study we found average HbA1C (%) in Treadmill test positive and negative cases were 9.7and7.7 respectively. Statistically significant value of p<0.001 was found in HbA1C (%) levels between both the groups.One study 18 found that among those who had diabetes mellitus, silent myocardial ischemia was present 27 of 54patients (50%) who had hemoglobin A1clevel>or=7.6% and in 39 of 137 (28%) with hemoglobin A1c level (p<0.005).In one more 21 study, it shows eloquent increasing trend of HbA1c levels over the augmenting number of coronary vessels involvement with CAD (p<0.0001).
VI. Conclusion
In our study population, the preponderance of SMI in type 2DM, without previous clinical and electrocardiographic signs of ischemic heart disease or hypertension is 30%.Duration of diabetes mellitus is directly proportional to increased risk of silent ischemia in type 2 DM. Triglyceride was found to be in higher levels in persons who had silent ischemia. Patients who had greater prevalence of silent myocardial ischemia on TMT were found to have higher glycosylated hemoglobin levels.
Diabetics with clinical signs of autonomic neuropathy had higher incidence of silent myocardial ischemia. Age, duration of diabetes, triglyceride levels, autonomic neuropathy and glycosylated hemoglobin are strong clinical predictors of silent myocardial ischemia. Early detection of outpatients with type 2 DM for SMI may prevent catastrophic cardiac events.Based on our study, a routine screening for Silent Myocardial Ischemia in asymptomatic type 2 DM outpatients who had longer duration of diabetes, high triglycerides and HbA1C levels.
